Avanos Medical (AVNS) Competitors

$24.72 +0.02 (+0.06%)

Closing price 05/15/2026 03:59 PM Eastern

Extended Trading

$24.72 -0.01 (-0.02%)

As of 05/15/2026 04:10 PM Eastern

AVNS vs. SNAL, LQDA, NVST, IRTC, and LIVN

Should you buy Avanos Medical stock or one of its competitors? MarketBeat compares Avanos Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avanos Medical include Snail (SNAL), Liquidia (LQDA), Envista (NVST), iRhythm Technologies (IRTC), and LivaNova (LIVN).

How does Avanos Medical compare to Snail?

Snail (NASDAQ:SNAL) and Avanos Medical (NYSE:AVNS) are related small-cap companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Avanos Medical has a net margin of -10.39% compared to Snail's net margin of -11.73%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Snail	-11.73%	-15.49%	5.24%
Avanos Medical	-10.39%	5.39%	3.97%

In the previous week, Snail had 21 more articles in the media than Avanos Medical. MarketBeat recorded 23 mentions for Snail and 2 mentions for Avanos Medical. Snail's average media sentiment score of 0.53 beat Avanos Medical's score of 0.00 indicating that Snail is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Snail	5 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Snail has higher earnings, but lower revenue than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Snail	$81.23M	0.54	-$27.24M	-$0.62	N/A
Avanos Medical	$701.20M	1.65	-$72.90M	-$1.61	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Snail	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Snail has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market.

0.4% of Snail shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 68.3% of Snail shares are owned by insiders. Comparatively, 2.3% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Snail beats Avanos Medical on 9 of the 15 factors compared between the two stocks.

How does Avanos Medical compare to Liquidia?

Liquidia (NASDAQ:LQDA) and Avanos Medical (NYSE:AVNS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Liquidia has a net margin of 7.74% compared to Avanos Medical's net margin of -10.39%. Liquidia's return on equity of 46.82% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Liquidia	7.74%	46.82%	7.06%
Avanos Medical	-10.39%	5.39%	3.97%

In the previous week, Liquidia had 52 more articles in the media than Avanos Medical. MarketBeat recorded 54 mentions for Liquidia and 2 mentions for Avanos Medical. Liquidia's average media sentiment score of 0.61 beat Avanos Medical's score of 0.00 indicating that Liquidia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Liquidia	17 Very Positive mention(s)	9 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Avanos Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Liquidia has higher earnings, but lower revenue than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Liquidia	$158.32M	31.98	-$68.92M	$0.14	406.64
Avanos Medical	$701.20M	1.65	-$72.90M	-$1.61	N/A

Liquidia currently has a consensus price target of $49.33, suggesting a potential downside of 13.34%. Given Liquidia's stronger consensus rating and higher possible upside, analysts clearly believe Liquidia is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Liquidia	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	3 Strong Buy rating(s)	2.92
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Liquidia has a beta of 0.41, suggesting that its share price is 59% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market.

64.5% of Liquidia shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 25.6% of Liquidia shares are owned by insiders. Comparatively, 2.3% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Liquidia beats Avanos Medical on 14 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to Envista?

Envista (NYSE:NVST) and Avanos Medical (NYSE:AVNS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

Envista currently has a consensus target price of $28.83, suggesting a potential upside of 24.09%. Given Envista's stronger consensus rating and higher possible upside, equities research analysts clearly believe Envista is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Envista has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market.

Envista has a net margin of 2.41% compared to Avanos Medical's net margin of -10.39%. Envista's return on equity of 7.11% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Avanos Medical	-10.39%	5.39%	3.97%

In the previous week, Envista had 4 more articles in the media than Avanos Medical. MarketBeat recorded 6 mentions for Envista and 2 mentions for Avanos Medical. Envista's average media sentiment score of 0.54 beat Avanos Medical's score of 0.00 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.39	$47M	$0.41	56.67
Avanos Medical	$701.20M	1.65	-$72.90M	-$1.61	N/A

95.2% of Avanos Medical shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 2.3% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Envista beats Avanos Medical on 11 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to iRhythm Technologies?

Avanos Medical (NYSE:AVNS) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

iRhythm Technologies has a consensus target price of $193.38, suggesting a potential upside of 69.64%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.93

Avanos Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.33, suggesting that its share price is 33% more volatile than the broader market.

iRhythm Technologies has a net margin of -3.53% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

In the previous week, iRhythm Technologies had 4 more articles in the media than Avanos Medical. MarketBeat recorded 6 mentions for iRhythm Technologies and 2 mentions for Avanos Medical. iRhythm Technologies' average media sentiment score of 1.34 beat Avanos Medical's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
iRhythm Technologies	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies has higher revenue and earnings than Avanos Medical. iRhythm Technologies is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.65	-$72.90M	-$1.61	N/A
iRhythm Technologies	$747.14M	5.01	-$44.55M	-$0.86	N/A

95.2% of Avanos Medical shares are held by institutional investors. 2.3% of Avanos Medical shares are held by company insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

iRhythm Technologies beats Avanos Medical on 11 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to LivaNova?

Avanos Medical (NYSE:AVNS) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 2.3% of Avanos Medical shares are held by company insiders. Comparatively, 0.4% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Avanos Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

LivaNova has a consensus target price of $77.22, suggesting a potential upside of 10.32%. Given LivaNova's stronger consensus rating and higher probable upside, analysts plainly believe LivaNova is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LivaNova	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

In the previous week, LivaNova had 1 more articles in the media than Avanos Medical. MarketBeat recorded 3 mentions for LivaNova and 2 mentions for Avanos Medical. LivaNova's average media sentiment score of 0.98 beat Avanos Medical's score of 0.00 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LivaNova	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LivaNova has a net margin of 7.48% compared to Avanos Medical's net margin of -10.39%. LivaNova's return on equity of 16.48% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
LivaNova	7.48%	16.48%	7.59%

Avanos Medical has higher earnings, but lower revenue than LivaNova. Avanos Medical is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.65	-$72.90M	-$1.61	N/A
LivaNova	$1.39B	2.77	-$242.47M	$1.95	35.90

Summary

LivaNova beats Avanos Medical on 13 of the 16 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVNS vs. The Competition

Export

Metric	Avanos Medical	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$1.16B	$6.69B	$6.25B	$22.71B
Dividend Yield	N/A	1.76%	2.81%	4.12%
P/E Ratio	-15.36	49.11	20.40	29.73
Price / Sales	1.65	68.87	550.85	92.51
Price / Cash	7.21	24.43	27.48	18.80
Price / Book	1.48	6.45	9.74	4.57
Net Income	-$72.90M	$158.81M	$3.57B	$1.07B
7 Day Performance	-0.32%	-2.05%	-1.05%	-1.80%
1 Month Performance	0.37%	-6.28%	-2.62%	-1.67%
1 Year Performance	88.51%	-4.45%	33.52%	21.94%

Avanos Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVNS Avanos Medical	0.4189 of 5 stars	$24.73 +0.1%	N/A	+88.5%	$1.16B	$701.20M	N/A	2,287	Short Interest Decrease
SNAL Snail	2.0303 of 5 stars	$0.47 -1.8%	N/A	+16.0%	$18.12M	$81.23M	N/A	60	Earnings Report Analyst Revision Gap Up
LQDA Liquidia	2.8725 of 5 stars	$51.81 -2.5%	$46.78 -9.7%	+201.5%	$4.61B	$158.32M	N/A	50	Trending News Earnings Report Analyst Upgrade Insider Trade
NVST Envista	3.6306 of 5 stars	$24.40 +0.6%	$28.83 +18.2%	+27.4%	$3.94B	$2.72B	58.91	12,000
IRTC iRhythm Technologies	4.5665 of 5 stars	$117.04 +0.2%	$193.38 +65.2%	-19.1%	$3.88B	$747.14M	N/A	2,400

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVNS) was last updated on 5/18/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, LQDA, NVST, IRTC, and LIVN

How does Avanos Medical compare to Snail?

Summary

How does Avanos Medical compare to Liquidia?

Summary

How does Avanos Medical compare to Envista?

Summary

How does Avanos Medical compare to iRhythm Technologies?

Summary

How does Avanos Medical compare to LivaNova?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, LQDA, NVST, IRTC, and LIVN

How does Avanos Medical compare to Snail?

Is SNAL or AVNS more profitable?

Does the media prefer SNAL or AVNS?

Which has stronger earnings and valuation, SNAL or AVNS?

Do analysts rate SNAL or AVNS?

Which has more risk and volatility, SNAL or AVNS?

Do institutionals and insiders have more ownership in SNAL or AVNS?

Summary

How does Avanos Medical compare to Liquidia?

Is LQDA or AVNS more profitable?

Does the media prefer LQDA or AVNS?

Which has stronger earnings and valuation, LQDA or AVNS?

Do analysts rate LQDA or AVNS?

Which has more risk and volatility, LQDA or AVNS?

Do institutionals and insiders have more ownership in LQDA or AVNS?

Summary

How does Avanos Medical compare to Envista?

Do analysts rate NVST or AVNS?

Which has more risk & volatility, NVST or AVNS?

Is NVST or AVNS more profitable?

Does the media favor NVST or AVNS?

Which has higher earnings & valuation, NVST or AVNS?

Do insiders & institutionals have more ownership in NVST or AVNS?

Summary

How does Avanos Medical compare to iRhythm Technologies?

Do analysts recommend AVNS or IRTC?

Which has more volatility and risk, AVNS or IRTC?

Is AVNS or IRTC more profitable?

Does the media favor AVNS or IRTC?

Which has better earnings and valuation, AVNS or IRTC?

Do institutionals & insiders have more ownership in AVNS or IRTC?

Summary

How does Avanos Medical compare to LivaNova?

Do institutionals & insiders have more ownership in AVNS or LIVN?

Which has more volatility and risk, AVNS or LIVN?

Do analysts recommend AVNS or LIVN?

Does the media favor AVNS or LIVN?

Is AVNS or LIVN more profitable?

Which has better earnings and valuation, AVNS or LIVN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools